PharmAust (ASX:PAA) Share Price and News

Market Cap (17-Dec) $111,926,056 (1,449th)	Close (30-Jun) $0.075 0 (0%)	Volume (30-Jun) 0	Shortsold (11-Oct) 108,089 (0.02%) (492nd)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.02

	Subject
	PAA PAA Ann: Results of General Meeting
	1 (current) 2 3
	PAA PAA Ann: Trading Halt
	PAA PAA Ann: General Meeting - Chairman Script
	PAA PAA Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update
	PAA PAA Ann: Commencement of Cohort 3 in Phase 1/2 MND Trial
	PAA PAA Ann: PharmAust MND Trial Interim Analysis PK Outcomes
	PAA PAA Ann: Trading Halt
	PAA PAA Ann: Notice of General Meeting/Proxy Form
	PAA PAA Ann: Motor Neurone Disease Clinical Trial Update
	PAA PAA Ann: Securities issued under LR7.1 & LR7.1A
	PAA PAA Ann: Progress update on Phase 1/2 MND interim analysis
	PAA PAA Ann: Application for quotation of securities - PAA
	PAA PAA Ann: Cancel - Notification regarding unquoted securities - PAA
	PAA PAA Ann: Notification regarding unquoted securities - PAA
	PAA PAA Ann: Terms & Conditions of Unlisted Options
	PAA PAA Ann: Appendix 3Y
	PAA PAA Ann: Section 708(5) Notice
	PAA PAA Ann: Notification regarding unquoted securities - PAA
	PAA PAA Ann: Notification regarding unquoted securities - PAA
	PAA PAA Ann: Application for quotation of securities - PAA
	PAA PAA Ann: Independent tests show MPL retains long-term shelf-life
	PAA PAA Ann: MPL has anti-cancer effects across multiple cancer types
	PAA PAA Ann: Proposed issue of securities - PAA
	PAA PAA Ann: PharmAust Raises $2.5m via Placement
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: Trading Halt
	PAA PAA Ann: MND Trial Successfully Completes Second Patient Cohort
	PAA PAA Ann: Canine Trial Update
	PAA PAA Ann: Arrival of additional MPL tablets
	PAA PAA Ann: PharmAust launches international CEO search
	PAA PAA Ann: MND Trial Completes Enrolment of Cohort 2
	PAA PAA Ann: Stable Patient in MND trial reaches 6-months on MPL
	PAA PAA Ann: PharmAust Investor Webinar Presentation
	PAA PAA Ann: AOG Energy Conference Presentation
	PAA PAA Ann: Investor Webinar
	PAA PAA Ann: Correction to Appendix 3Y
	PAA PAA Ann: Change of Director's Interest Notice
	PAA PAA Ann: Canine Cancer Trial Update
	PAA PAA Ann: Interim analysis recommended in MND trial
	PAA PAA Ann: European Patent relating to MPL Combinations in Cancer
	PAA PAA Ann: Appendix 4D & Half Year Report
	PAA PAA Ann: First Patient of Cohort 2 Dosed in MND Trial
	PAA PAA Ann: PharmAust canine trial update
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: PharmAust Progresses to Elevated Doses in MND Patients
	PAA PAA Ann: Change of Director's Interest Notice
	PAA PAA Ann: MND Trial Successfully Completes First Patient Cohort
	PAA PAA Ann: PharmAust Canine Trial Update clarification
	PAA PAA Ann: PharmAust Canine Trial Update
	PAA PAA Ann: PharmAust Receives R&D Tax Incentive Refund

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
16-Dec	$0.17	882,169	-0.02 (8.33%)
13-Dec	$0.18	127,632	-0.01 (2.70%)
12-Dec	$0.19	382,091	+0.01 (5.71%)
11-Dec	$0.18	620,427	0.00 (0.00%)
09-Dec	$0.18	105,356	+0.00 (2.94%)
06-Dec	$0.17	261,837	+0.01 (6.25%)
05-Dec	$0.16	889,407	-0.02 (11.11%)
03-Dec	$0.18	65,135	+0.01 (2.86%)
02-Dec	$0.18	490,456	-0.01 (5.41%)
29-Nov	$0.19	163,628	+0.01 (5.71%)
28-Nov	$0.18	217,540	0.00 (0.00%)
27-Nov	$0.18	1,424,745	-0.01 (5.41%)
26-Nov	$0.19	414,413	-0.01 (2.63%)
25-Nov	$0.19	308,103	0.00 (0.00%)
22-Nov	$0.19	750,714	0.00 (0.00%)
5 up, 6 down, and 4 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
5 June 2026 at 1:03am

High -	Low -	Trades -	Turnover $0	Volume 0
5 June 2026 at 1:03am

PharmAust Health Care

$0.075 (0%)

$0.075 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices